Yang Hongbin, Zhang Xiaotong, Lu Yanjie, Wang Xin, Zhang Zhengxin, Xu Hailan, Li Fan, Chen Qianhui, Bai Yiying, Bai Xinyu, Zhang Li, Liu Lei
Department of Immunology, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China.
Department of Pathology Chengde Medical University, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China.
Mol Clin Oncol. 2024 Feb 5;20(3):25. doi: 10.3892/mco.2024.2723. eCollection 2024 Mar.
Ailanthone (AIL), a monomer derived from ailanthus in Chinese medicine, has been demonstrated to have antitumor effects, albeit the underlying mechanism is unknown. Autophagy and ferroptosis are two modes of cell death that have been championed as potential mechanisms implicated in the antitumor effects of various drugs. The present study demonstrated that AIL effectively suppresses the Lewis cell proliferation in non-small cell lung cancer using MTT and colony formation assays. Autophagy and ferroptosis were verified using western blotting, immunofluorescence and ferroptosis detection. Additionally, the findings revealed that regulating the AMPK/mTOR/p70S6k signaling pathway may be the underlying mechanism for the antitumor effect of AIL. The present study established a theoretical foundation for further research into the utilization of AIL as a novel antitumor approach.
樗酮(AIL)是一种源自中药臭椿的单体,已被证明具有抗肿瘤作用,但其潜在机制尚不清楚。自噬和铁死亡是两种细胞死亡模式,被认为是各种药物抗肿瘤作用的潜在机制。本研究通过MTT和集落形成试验证明,AIL能有效抑制非小细胞肺癌中Lewis细胞的增殖。通过蛋白质免疫印迹、免疫荧光和铁死亡检测对自噬和铁死亡进行了验证。此外,研究结果表明,调节AMPK/mTOR/p70S6k信号通路可能是AIL发挥抗肿瘤作用的潜在机制。本研究为进一步研究将AIL用作新型抗肿瘤方法奠定了理论基础。